FDA Inspection 1269958 — Institute for Reproductive Health

Institute for Reproductive Health — FEI 3004562849

The FDA completed an inspection of Institute for Reproductive Health on May 15, 2025 in Cincinnati, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 15, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Cincinnati, OH (United States)